Trials / Completed
CompletedNCT05630027
A Scalp Lotion Toimprove Sensitive Scalp Syndrome
Soothing and Anti-hair Loss Activity of a Scalp Lotion Containing Piroctone Olamine, 2,4 Diaminopyrimidine Oxide and Vichy Mineralizing Water
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Cosmetique Active International · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Overall, 100 Caucasian subjects participated in this 6-weeks lasting study, AC5+ was applied daily. All subjects had clinically confirmed mild to moderate alopecia and self-declared sensitive scalp. Instrumental assessments included Trans Epidermal Water Loss (TEWL), inflammation markers, clinical assessments included the severity of erythema, inflammation and greasiness. Subjective/Self assessments comprised the intensity of the scalp itch/pruritus and the evaluation of their head hair status (volume, abundance, strength). Same assessments were provided by the investigators.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Piroctone Olamine (PO), 2,4 Diaminopyrimidine oxide (2.4 DA) and Vichy mineralizing water | observational, prospective study |
Timeline
- Start date
- 2019-01-02
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
- First posted
- 2022-11-29
- Last updated
- 2022-11-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05630027. Inclusion in this directory is not an endorsement.